Last reviewed · How we verify
Gastrografin®: G
Gastrografin is a water-soluble iodinated contrast medium that opacifies the gastrointestinal tract for radiographic imaging.
Gastrografin is a water-soluble iodinated contrast medium that opacifies the gastrointestinal tract for radiographic imaging. Used for Radiographic visualization of the gastrointestinal tract, Diagnosis of gastrointestinal obstruction and perforation, Evaluation of suspected bowel obstruction in neonates and infants.
At a glance
| Generic name | Gastrografin®: G |
|---|---|
| Also known as | water-soluble contrast medium (Gastrografin®: G) meal |
| Sponsor | University of Bologna |
| Drug class | Iodinated contrast medium |
| Modality | Small molecule |
| Therapeutic area | Diagnostic Imaging |
| Phase | FDA-approved |
Mechanism of action
Gastrografin contains sodium diatrizoate and meglumine diatrizoate, iodinated compounds that absorb X-rays and render the GI tract radiopaque. It is administered orally or rectally and distributes throughout the gastrointestinal lumen, allowing visualization of anatomical structures and pathology on radiographic examination. The iodine content provides the radiopacity necessary for diagnostic imaging.
Approved indications
- Radiographic visualization of the gastrointestinal tract
- Diagnosis of gastrointestinal obstruction and perforation
- Evaluation of suspected bowel obstruction in neonates and infants
Common side effects
- Osmotic diarrhea
- Nausea
- Abdominal cramping
- Allergic reaction (iodine sensitivity)
- Aspiration pneumonia (if aspirated)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Gastrografin®: G CI brief — competitive landscape report
- Gastrografin®: G updates RSS · CI watch RSS
- University of Bologna portfolio CI